Correspondence 0001493152-24-034820 from ORAGENICS INC (OGEN)
ORAGENICS INC
Date: Sept. 3, 2024 · CIK: 0001174940 · Accession: 0001493152-24-034820
AI Filing Summary & Sentiment
File numbers found in text: 333-281618
Show Raw Text
CORRESP
1
filename1.htm
DAWSON
JAMES SECURITIES INC.
101
North Federal Highway
Suite
600
Boca
Raton, Fl 33432
September
3, 2024
VIA
EDGAR
Division
of Corporation Finance
Office
of Life Sciences
U.S.
Securities & Exchange Commission
100
F Street, NE
Washington,
D.C. 20549-3628
Attn:
Jimmy McNamara
RE:
Oragenics, Inc. (the “Company”)
Registration Statement on Form S-1
(File No. 333-281618) (the “Registration Statement”)
Dear
Mr. McNamara:
Dawson
James Securities Inc., the placement agent in the offering contemplated in the Registration Statement, hereby requests, pursuant to Rule
461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such
Registration Statement will become effective as of 4:30 P.M. Eastern Time on Tuesday, September 3, 2024, or as soon thereafter as practicable.
Once
the Registration Statement has been declared effective, please orally confirm that event with Mark Catchur, of Shumaker, Loop & Kendrick,
LLP, counsel to the Company, at (813) 227-2264.
Very
truly yours,
DAWSON
JAMES SECURITIES INC.
By:
/s/
Robert D. Keyser, Jr.
Name:
Robert
D. Keyser, Jr.
Title:
Chief
Executive Officer